GSK plc (LON:GSK – Get Free Report)’s share price passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 1,444 ($18.73) and traded as high ...
Eli Lilly CEO Dave Ricks made $114 million last year, according to a new proxy statement, a rare instance of a health ...
In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target ...
Fortune curated a list of female leaders at the helm of European companies across the continent’s biggest industries.
CBO Abbas Kazimi will replace longtime CEO Jeb Keiper as part of a planned leadership transition at the unorthodox drug ...
In 2024, Bayer chief Bill Anderson’s total compensation fell about 21% to 8.84 million euros ($9.6 million). The decline ...
Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The ...
The British pharma giant said Emma Walmsley's current pay could put off candidates for her eventual successor.
For GSK CEO Emma Walmsley, there was good news and bad news in the company’s annual report. | For GSK CEO Emma Walmsley, ...
GSK on Thursday also proposed increasing the annual ... to provide the appropriate capacity for succession". AstraZeneca CEO Pascal Soriot earned 14.7 million pounds in 2024 and could earn as ...
GSK said it is dropping its diversity and inclusion targets, joining a growing list of companies retreating from initiatives to diversify their workforces and leadership teams amid a legal and ...
One of the lowest paid CEOs in pharma—and one of the only woman leading a top-tier giant—is set to receive up to $27.2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results